Industrial performance issues: quality, productivity and traceability
The pharmaceutical industry is in the midst of a major transformation, with fundamental trends linked to the redesign of the entire production chain, from basic molecules to finished products and active ingredients. The main objective of this transformation is to be able to ensure the security of medicines supply, both in terms of volume and quality, while ensuring the level of traceability required by the GxP framework.
As far as the latter is concerned, the link with performance is much closer than it might seem. Traceability is an essential link to be able to investigate in order to resolve a crisis but also to work on performance by facilitating or making possible the investigation that is essential to the functioning of the improvement loop.
Enabling and simplifying access to the information teams need
To meet these issues, one of the challenges for the pharmaceutical industry is the structuring and aggregation of data to be able to know the detailed history of a production batch at a sufficiently fine scale.
Our tools allow our customers to collect their data directly from their industrial information systems and to combine them with data from business systems (PGI, LIMS, MES, etc.).
In this way, our clients can:
- combine their data to transform them into relevant information (e.g. sterilisation schedule for a production batch automatically calculated from timing data and on-line temperature measurements; calculation of yields per batch, per product, etc.),
- use their data to control their process parameters with statistical control charts and thus control the quality of the finished product and meet the regulatory requirements for monitoring production processes,
- improve their productivity by monitoring the OEE of their lines by capturing a maximum amount of information on the equipment to automatically qualify the causes of stoppages, under-cadence, etc.
- implement monitoring summaries by production batch (EBR, Electronic Batch Record) with all the critical parameters, and a validation process by batch for simplified traceability. Thus, the treatment of a non-conformity or an incident on a batch is drastically accelerated by having all the necessary information on the life of the batch at hand.
From the reception of raw materials to the packaging of finished products, through the transformation processes (fermentation, extraction, purification, synthesis, mixing and formulation…), our solutions make it possible to respond to the various challenges of the plant by simplifying the use of data.
An approach to facilitate GxP management
We have worked to develop our solutions so that they can be easily implemented in a GMP/GxP context thanks to functionalities that meet the requirements of Gamp v5 as well as the needs of qualification activities. In particular, the configuration of our solutions has a 100% audit trail, and our data storage systems implement strategies to meet ALCOA+… Our ambition in this area is to make operation in a GxP environment more agile.
Enable to go further by activating the levers offered by Data Analytics and Machine Learning
To go further, our clients can take the next step thanks to our solutions with an approach that combines the flexibility and agility of a field approach while capitalising on the company’s business, process and data experts:
- A field approach that provides process engineers with powerful yet simple tools to better understand the variability of their processes. They can thus reinforce the level of control over certain parameters that generate non-quality.
- A “data” approach that allows data scientists and data analysts to save time both in the constitution of their datasets, to make their studies and their models, but also to be able to rapidly deploy their models thanks to the Python code execution capabilities of our solutions.
An opportunity for the pharmaceutical industry to make its digital transformation
The pharmaceutical industry is a particular sector, in that industrial information systems are focused on the regulatory and qualification aspects. We propose an approach that keeps this constraint in mind while putting performance back in the foreground by restoring agility to organisations.